Table 1 Clinical and demographic data of the baseline population
From: Quality indicators in type 2 diabetes patient care: analysis per care-complexity level
ESF | UBS | Tertiary health care | P | |
|---|---|---|---|---|
(N = 148) | (N = 148) | (N = 192) | ||
Sex (% female) | 95 (64.2a) | 93 (62.8b) | 92 (47.9b) | 0.003 |
Skin color (% white) | 133 (89.9) | 139 (93.9) | 167 (87.0) | 0.11 |
Age (years)1 | 68.5a ± 10.4 | 68.0a ± 10.6 | 63.5b ± 10.2 | < 0.001 |
Education (% complete secondary school)2 | 53 (37.6a) | 13 (46.4a) | 39 (22.2b) | 0.002 |
Occupation (% active) | 30 (22.4a) | 11 (45.8b) | 65 (38.7b) | 0.004 |
HbA1c %2 | 7.60a ± 1.7 | 7.9a ± 1.8 | 8.6b ± 2.0 | < 0.001 |
Hypertension, n (%)2 | 127 (85.8ab) | 117 (79.1b) | 178 (92.7a) | 0.001 |
Dyslipidemia, n (%) | 102 (68.9) | 96 (64.9) | 140 (72.9) | 0.28 |
Depression, n (%) | 30 (20.3) | 26 (17.6) | 36 (18.8) | 0.84 |
Diabetes complications, n (%)2 | 25 (16.9a) | 19 (12.8a) | 110 (57.3b) | < 0.001 |
Statin, n (%) | 102 (68.9) | 87 (58.8) | 134 (69.8) | 0.08 |
Metformin, n (%) | 127 (85.8a) | 128 (86.5a) | 144 (75.0b) | 0.009 |
NPH insulin, n (%) | 31 (20.9a) | 25 (16.9a) | 128 (66.7b) | < 0.001 |
Regular insulin, n (%) | 2 (1.4a) | 3 (2.0a) | 50 (26.0b) | < 0.001 |